A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Clinical trial NCT00224029 · COMPLETED

Trial details

NCT number: NCT00224029
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Detrusor Hyperreflexia

Start date: 2004-12-01
Primary completion: 2005-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.